Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
RAD Induction and Risk-Adapted Transplant in Multiple Myeloma
NCT00925821Phase 2Completed
- Start
- Jun 2009
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of lenalidomide in multiple myeloma (MM). Started Jun 2009; status: completed.
02
Drugs
lenalidomide
03
Conditions
multiple myeloma (MM)
Beyond the preview
Go deeper on NCT00925821.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00925821.